GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IDEAYA Biosciences Inc (FRA:30J) » Definitions » Forward Dividend Yield %

IDEAYA Biosciences (FRA:30J) Forward Dividend Yield % : 0.00% (As of May. 12, 2025)


View and export this data going back to 2019. Start your Free Trial

What is IDEAYA Biosciences Forward Dividend Yield %?

As of today (2025-05-12), the Forward Annual Dividend Yield of IDEAYA Biosciences is 0.00%.

As of today (2025-05-12), the Trailing Annual Dividend Yield of IDEAYA Biosciences is 0.00%.

FRA:30J's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.54
* Ranked among companies with meaningful Forward Dividend Yield % only.

IDEAYA Biosciences's Dividends per Share for the three months ended in Mar. 2025 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of IDEAYA Biosciences's Forward Dividend Yield %

For the Biotechnology subindustry, IDEAYA Biosciences's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDEAYA Biosciences's Forward Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IDEAYA Biosciences's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where IDEAYA Biosciences's Forward Dividend Yield % falls into.


;
;

IDEAYA Biosciences Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


IDEAYA Biosciences  (FRA:30J) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


IDEAYA Biosciences Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of IDEAYA Biosciences's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


IDEAYA Biosciences Business Description

Traded in Other Exchanges
Address
5000 Shoreline Court, Suite 300, South San Francisco, CA, USA, 94080
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

IDEAYA Biosciences Headlines

No Headlines